Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,975
Closed -$46.5K 4315
2024
Q2
$46.5K Buy
25,975
+44
+0.2% +$81 ﹤0.01% 4155
2024
Q1
$46.7K Buy
25,931
+275
+1% +$638 ﹤0.01% 4175
2023
Q4
$78.8K Buy
25,656
+1,892
+8% +$5.14K ﹤0.01% 4101
2023
Q3
$71.8K Buy
23,764
+770
+3% +$2.38K ﹤0.01% 4196
2023
Q2
$68.1K Buy
22,994
+891
+4% +$2.76K ﹤0.01% 4324
2023
Q1
$71.6K Buy
22,103
+2,013
+10% +$6.49K ﹤0.01% 4416
2022
Q4
$52.2K Buy
20,090
+2,101
+12% +$4.28K ﹤0.01% 4548
2022
Q3
$40K Buy
17,989
+990
+6% +$2.16K ﹤0.01% 4704
2022
Q2
$40K Sell
16,999
-132
-0.8% -$348 ﹤0.01% 4764
2022
Q1
$37K Buy
17,131
+2,497
+17% +$5.98K ﹤0.01% 4843
2021
Q4
$41K Sell
14,634
-66
-0.4% -$283 ﹤0.01% 4728
2021
Q3
$69K Buy
+14,700
New +$109K ﹤0.01% 4611

Other funds holding IH

State Street's IH Position: Q3 2024 in Review

State Street sold out of iHuman (IH) in Q3 2024, closing a stake of 25,975 shares — an estimated $46.5K sold.

State Street first reported a position in IH in Q3 2021 and held it in 12 quarters. The position peaked at $78.8K in Q4 2023. 6 funds tracked by Wall St. Rank hold IH as of Q3 2024.

  • State Street reported no remaining iHuman position as of Q3 2024 after selling out during the quarter.
  • State Street sold 25,975 iHuman shares in Q3 2024, an estimated $46.5K.
  • State Street first reported a position in iHuman in Q3 2021 and held it in 12 quarters.
  • State Street's iHuman position peaked at $78.8K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held iHuman as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.